4.8 Article

High burden and pervasive positive selection of somatic mutations in normal human skin

期刊

SCIENCE
卷 348, 期 6237, 页码 880-886

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aaa6806

关键词

-

资金

  1. Wellcome Trust [077012/Z/05/Z, WT088340MA]
  2. Medical Research Council (MRC)
  3. Cancer Research UK (CRUK) [C609/A17257]
  4. EMBO [1287-2012]
  5. Queens' College, Cambridge
  6. CRUK-Cambridge Cancer Centre Clinical Research Fellowship
  7. Marie Curie Fellowship FP7-PEOPLE-IEF [328264]
  8. Cancer Research UK [17257] Funding Source: researchfish
  9. Medical Research Council [MC_UU_12022/3] Funding Source: researchfish
  10. The Francis Crick Institute [10202] Funding Source: researchfish
  11. MRC [MC_UU_12022/3] Funding Source: UKRI

向作者/读者索取更多资源

How somatic mutations accumulate in normal cells is central to understanding cancer development but is poorly understood. We performed ultradeep sequencing of 74 cancer genes in small (0.8 to 4.7 square millimeters) biopsies of normal skin. Across 234 biopsies of sun-exposed eyelid epidermis from four individuals, the burden of somatic mutations averaged two to six mutations per megabase per cell, similar to that seen in many cancers, and exhibited characteristic signatures of exposure to ultraviolet light. Remarkably, multiple cancer genes are under strong positive selection even in physiologically normal skin, including most of the key drivers of cutaneous squamous cell carcinomas. Positively selected mutations were found in 18 to 32% of normal skin cells at a density of similar to 140 driver mutations per square centimeter. We observed variability in the driver landscape among individuals and variability in the sizes of clonal expansions across genes. Thus, aged sun-exposed skin is a patchwork of thousands of evolving clones with over a quarter of cells carrying cancer-causing mutations while maintaining the physiological functions of epidermis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据